Medpace Holdings, Inc. (MEDP) earnings
MEDP earnings moved a median of +0.31% by the close. Quarterly and annual MEDP reports and results, each read against the price at its own news timestamp. Back to the MEDP overview →
30 measured MEDP earnings events.
Where these MEDP earnings landedvs 30 measured MEDP earnings reactions
| Middle 50% of MEDP earnings reactions | -1.97% to +5.16% |
|---|---|
| Median reaction (to close) | +0.31% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 MEDP earnings events with a measured close landed between -1.97% and +5.16%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 | Press release | +0.51% | -2.05% | |
| Form 10-Q Medpace Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.13% | -1.75% | |
| Medpace Holdings, Inc. Reports Second Quarter 2026 Results | Press release | +0.61% | -6.37% | |
| Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 | Press release | -0.04% | -0.00% | |
| Form 10-Q Medpace Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.81% | +5.26% | |
| Medpace Holdings, Inc. Reports First Quarter 2026 Results | Press release | +4.51% | +4.91% | |
| Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026 | Press release | +0.85% | +0.26% | |
| Form 10-K Medpace Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.83% | -4.33% | |
| Form 10-Q Medpace Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.91% | +0.36% | |
| Medpace Holdings, Inc. Reports Third Quarter 2025 Results | Press release | -0.97% | -3.16% | |
| Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025 | Press release | +0.56% | -0.26% | |
| Form 10-Q Medpace Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.56% | -7.07% | |
| Medpace Holdings, Inc. Reports Second Quarter 2025 Results | Press release | +3.60% | +7.21% | |
| Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025 | Press release | +0.38% | +1.97% | |
| Form 10-Q Medpace Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.91% | -0.98% | |
| Medpace Holdings, Inc. Reports First Quarter 2025 Results | Press release | -2.94% | +8.93% | |
| Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025 | Press release | +0.60% | +1.77% | |
| Form 10-K Medpace Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.19% | +2.89% | |
| Form 10-Q Medpace Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.83% | +1.10% | |
| Medpace Holdings, Inc. Reports Third Quarter 2024 Results | Press release | +0.90% | +7.06% | |
| Medpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024 | Press release | -3.49% | -7.37% | |
| Form 10-Q Medpace Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.23% | +6.88% | |
| Medpace Holdings, Inc. Reports Second Quarter 2024 Results | Press release | +1.91% | -1.40% | |
| Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024 | Press release | +0.76% | +4.69% | |
| Form 10-Q Medpace Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.99% | -4.20% | |
| Medpace Holdings, Inc. Reports First Quarter 2024 Results | Press release | -1.13% | +7.71% | |
| Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024 | Press release | -0.06% | -1.73% | |
| Form 10-K Medpace Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.97% | +5.24% | |
| Form 10-Q Medpace Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.01% | -2.88% | |
| Medpace Holdings, Inc. Reports Third Quarter 2023 Results | Press release | +2.12% | +8.91% |
Keep exploring
More MEDP: analyst actions → · SEC filings → · MEDP overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Acadia Healthcare Company, Inc. (ACHC) | 1,165 | -0.02% | 49% |
| Corcept Therapeutics Incorporated (CORT) | 1,158 | +0.11% | 53% |
| Epizyme, Inc. (EPZM) | 1,145 | +0.04% | 51% |
| Neogen Corporation (NEOG) | 1,143 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.